Pathophysiology and management of gastroparesis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Expert Review of Gastroenterology & Hepatology

• Publication date

  2009-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/egh.09.10PMID 19351287
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathophysiology and Management of Diabetic Gastropathy

  2012cited by this paper
• Association between changes in symptoms and gastric emptying in gastroparetic patients treated with gastric electrical stimulation

  2008cited by this paper
• Acotiamide hydrochloride (Z‐338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats

  2008cited by this paper
• Is gastric electrical stimulation an effective therapy for patients with drug-refractory gastroparesis?

  2008cited by this paper
• Gastroparesis-Related Hospitalizations in the United States: Trends, Characteristics, and Outcomes, 1995–2004

  2008cited by this paper
• Visceral hypersensitivity and impaired accommodation in refractory diabetic gastroparesis

  2008cited by this paper
• Predictive Factors for Clinical Improvement with Enterra Gastric Electric Stimulation Treatment for Refractory Gastroparesis

  2008cited by this paper
• Botulinum Toxin A for the Treatment of Delayed Gastric Emptying

  2008cited by this paper
• The Clinical Impact of Islet Transplantation

  2008cited by this paper
• Effect of itopride on gastric emptying in longstanding diabetes mellitus

  2008cited by this paper
• Changes in the gastric enteric nervous system and muscle: A case report on two patients with diabetic gastroparesis

  2008cited by this paper
• Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis.

  2008cited by this paper
• Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials

  2007cited by this paper
• Clinical trial: a randomized‐controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis

  2007cited by this paper
• Gastroparesis: symptoms, evaluation, and treatment.

  2007cited by this paper
• Comparison of gastric emptying of a nondigestible capsule to a radio‐labelled meal in healthy and gastroparetic subjects

  2007cited by this paper
• Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis – a randomized, multicentre, placebo‐controlled study

  2007cited by this paper
• Relationships between hypoglycaemia and gastric emptying abnormalities in insulin‐treated diabetic patients 1

  2006cited by this paper
• Treatment of gastroparesis: a multidisciplinary clinical review

  2006cited by this paper
• A placebo-controlled trial of itopride in functional dyspepsia.

  2006cited by this paper
• A multimodal laser Doppler and endosonographic distension device for studying mechanosensation and mucosal blood flow in the oesophagus

  2006cited by this paper
• Measurements of gastric emptying of low‐ and high‐nutrient liquids using 3D ultrasonography and scintigraphy in healthy subjects

  2006cited by this paper
• Nutrition aspects of gastroparesis and therapies for drug-refractory patients.

  2006cited by this paper
• ‘Gastric’ hypoglycaemia – an important concept in diabetes management

  2006cited by this paper
• Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited?

  2006cited by this paper
• Abnormal Ghrelin and Pancreatic Polypeptide Responses in Gastroparesis

  2006cited by this paper
• Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes.

  2006cited by this paper
• Symptom responses, long‐term outcomes and adverse events beyond 3 years of high‐frequency gastric electrical stimulation for gastroparesis

  2006cited by this paper
• Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans

  2005cited by this paper
• Oral erythromycin and the risk of sudden death.

  2005cited by this paper
• Pathophysiology and Management of Diabetic Gastropathy

  2005cited by this paper
• Azithromycin as Novel Treatment for Gastroparesis?: 889

  2005cited by this paper
• New management approaches for gastroparesis

  2005cited by this paper
• Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long‐term health care benefits?

  2005cited by this paper
• Clinical response to gastric electrical stimulation in patients with postsurgical gastroparesis.

  2005cited by this paper
• Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study

  2005cited by this paper
• Influence of ghrelin on gastric emptying and meal‐related symptoms in idiopathic gastroparesis

  2005cited by this paper
• The Effect of sildenafil on gastric emptying in patients with end‐stage renal failure and symptoms of Gastroparesis

  2004cited by this paper
• American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis.

  2004cited by this paper
• Disruption of intestinal motility by a calcium channel-stimulating autoantibody in type 1 diabetes.

  2004cited by this paper
• Erythromycin in the Short- and Long-term Control of Dyspepsia Symptoms in Patients with Gastroparesis

  2004cited by this paper
• Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes.

  2004cited by this paper
• Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus

  2004cited by this paper
• Nitric oxide in gastrointestinal health and disease.

  2004cited by this paper
• Effect of prostoglandin inhibition with ketorolac on gastric activity and dyspeptic symptoms in patients with dyspeptic symptoms

  2003cited by this paper
• Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management

  2003cited by this paper
• Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy.

  2003cited by this paper
• Development and validation of a patient‐assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index

  2003cited by this paper
• A systematic review of surgical therapy for gastroparesis

  2003cited by this paper
• Diabetic Gastropathy and Prokinetics

  2003cited by this paper
• Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms

  2003cited by this paper
• Absence of the interstitial cells of cajal in patients with gastroparesis and correlation with clinical findings

  2003cited by this paper
• Gastric electrical stimulation for medically refractory gastroparesis.

  2003cited by this paper
• Clinical significance, pathogenesis, and management of postprandial hyperglycemia.

  2003cited by this paper
• A systematic review of surgical therapy for gastroparesis.

  2003cited by this paper
• Gastric emptying in diabetes: clinical significance and treatment

  2002cited by this paper
• Relationship between the Effects of Cisapride on Gastric Emptying and Plasma Glucose Concentrations in Diabetic Gastroparesis

  2002cited by this paper
• Dose finding study of mosapride in functional dyspepsia: a placebo‐controlled, randomized study

  2002cited by this paper
• Electroacupuncture accelerates gastric emptying in association with changes in vagal activity.

  2002cited by this paper
• A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus.

  2002cited by this paper
• Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle

  2002cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes

  2002influential reference
• Predictors of Response to a Behavioral Treatment in Patients with Chronic Gastric Motility Disorders

  2002cited by this paper
• Acute effect of clonidine on gastric emptying in patients with diabetic gastropathy and controls

  2002cited by this paper
• Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis.

  2002cited by this paper
• The Science and Practice of Nutrition Support: A Case-Based Core Curriculum

  2002cited by this paper
• Quality improvement in chronic illness care: a collaborative approach.

  2001cited by this paper
• Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults.

  2001cited by this paper
• Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying

  2001cited by this paper
• Relationships of upper gastrointestinal motor and sensory function with glycemic control.

  2001cited by this paper
• Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia

  2001cited by this paper
• Predictors of delayed gastric emptying in diabetes.

  2001cited by this paper
• Tricyclic antidepressants for persistent or recurrent vomiting in diabetic patients

  2001cited by this paper
• Diabetic gastroparesis improved by percutaneous endoscopic jejunostomy.

  2000cited by this paper
• Assessment of gastric emptying using a low fat meal: establishment of international control values

  2000cited by this paper
• Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy.

  2000cited by this paper
• The stimulation of antral motility by erythromycin is attenuated by hyperglycemia

  2000cited by this paper
• Novel testing of human gastric motor and sensory functions: rationale, methods, and potential applications in clinical practice

  2000cited by this paper
• The treatment of diabetic gastroparesis with botulinum toxin

  2000cited by this paper
• Failure of a motilin receptor agonist (ABT‐229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double‐blind placebo‐controlled trial

  2000cited by this paper
• Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes?

  2000cited by this paper
• Cholinergic effects on human gastric motility

  1999cited by this paper
• Simultaneous measurement of gastric emptying of a solid meal by ultrasound and by scintigraphy

  1999cited by this paper
• Pain: the overlooked symptom in gastroparesis

  1999cited by this paper
• Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus.

  1999cited by this paper
• Effects of duodenal distension on antropyloroduodenal pressures and perception are modified by hyperglycemia.

  1999cited by this paper
• Near-total completion gastrectomy for severe postvagotomy gastric stasis: Analysis of early and long-term results in 62 patients

  1999cited by this paper
• Prokinetics in Patients with Gastroparesis: A Systematic Analysis

  1999cited by this paper
• Novel surgical treatment and gastric pathology in diabetic gastroparesis

  1999cited by this paper
• Review article: cardiac adverse effects of gastrointestinal prokinetics

  1999cited by this paper
• Pain: the overlooked symptom in gastroparesis.

  1999cited by this paper
• Natural history of diabetic gastroparesis.

  1999cited by this paper
• Effects of duodenal distension on antropyloroduodenal pressures and perception are modified by hyperglycemia.

  1999cited by this paper
• Incubation of OKP cells in low-K+ media increases NHE3 activity after early decrease in intracellular pH.

  1999cited by this paper
• Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST).

  1999cited by this paper
• Nutrition screening and assessment.

  1999cited by this paper
• Safety and long-term durability of completion gastrectomy in 81 patients with postsurgical gastroparesis syndrome.

  1998cited by this paper
• Measurement of gastrointestinal motility in the GI laboratory.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Gastric pacing improves emptying and symptoms in patients with gastroparesis.

  1998cited by this paper

• The Association between Hormone Replacement Therapy and Gastroparesis in Post-Menopausal Women: A Worldwide Database Analysis

  2024cites this paper
• The Clinical Impacts Of Either Peripheral Or Central Lipofundin Mct/Lct-Amino Acid Co-Infusion Versus Central Amino Acid /Intermittent Lipofundin Mct/Lct In Severe Mal-Nourished Patients

  2020cites this paper
• Chronic Kidney Disease and Gastrointestinal Disorders

  2020cites this paper
• Opioid use disorder is associated with increased mortality and morbidity in patients with gastroparesis

  2019cites this paper
• The Physiology and pathophysiology of laparoscopic adjustable gastric bands

  2017cites this paper
• Gastric motility and emptying assessment by magnetic resonance imaging after lung transplantation: correlation with gastric emptying scintigraphy

  2017cites this paper
• Per-oral Endoscopic Pyloromyotomy

  2017cites this paper
• Title Usefulness of Omental Wrapping to Prevent Biliary Leakage and DelayedGastric Emptying in Left Hepatectomy

  2017cites this paper
• Gastric emptying and its relationship with postprandial glycaemic control in young people with cystic fibrosis and type 1 diabetes

  2015cites this paper
• The Evaluation of Solid Phase Gastric Emptying in Patients with Behcets Disease

  2015cites this paper
• Going, Going, Not Gone! Gastroparesis and How it Impacts Diabetes

  2015cites this paper
• Postprandial Plasma Glucose Response and Gastrointestinal Symptom Severity in Patients With Diabetic Gastroparesis

  2014cites this paper
• Xiangshaliujunzi Decoction for the treatment of diabetic gastroparesis: a systematic review.

  2014cites this paper
• Clinical Use of Botulinum Neurotoxin: Autonomic Conditions

  2014cites this paper
• Guidance: The practical management of the gastrointestinal symptoms of pelvic radiation disease

  2014cites this paper
• Effect of early enteral combined with parenteral nutrition in patients undergoing pancreaticoduodenectomy.

  2013cites this paper
• Recent Advances in the Pathophysiology and Treatment of Gastroparesis

  2013cites this paper
• Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives

  2013cites this paper
• Diagnosis & dietary intervention in patients with diabetic gastroparesis

  2013cites this paper
• Diabetic gastroparesis: recent insights into pathophysiology and implications for management

  2013cites this paper
• Acupuncture for symptomatic gastroparesis.

  2012cites this paper
• Usefulness of omental wrapping to prevent biliary leakage and delayed gastric emptying in left hepatectomy.

  2012cites this paper
• Allergic Mastocytic Gastroenteritis and Colitis: An Unexplained Etiology in Chronic Abdominal Pain and Gastrointestinal Dysmotility

  2012cites this paper
• Regional differences in neostigmine-induced contraction and relaxation of stomach from diabetic guinea pig.

  2011cites this paper
• Endoscopy in the Diagnosis and Management of Motility Disorders

  2011cites this paper
• Changes in Satiety, Supra- and Infraband Transit, and Gastric Emptying Following Laparoscopic Adjustable Gastric Banding: A Prospective Follow-up Study

  2011cites this paper
• Diabetic gastroparesis—Backwards and forwards

  2011cites this paper
• Management strategies for gastrointestinal, erectile, bladder, and sudomotor dysfunction in patients with diabetes

  2011cites this paper
• Gastrointestinal Manifestations of Diabetes

  2010cites this paper
• Tetrahydrobiopterin (BH4), a cofactor for nNOS, restores gastric emptying and nNOS expression in female diabetic rats.

  2010cites this paper
• Diabetic gastroparesis and its impact on glycemia.

  2010cites this paper
• Neue Kombinationstherapie bei diabetischer Gastroparese

  2009cites this paper